In anti-diabetes drug development, a clamping study is an effective way to accelerate early research efforts, and get the data to make better, more informed development decisions, while saving significant time and resources, as compared to traditional FIH and PoC clinical trials.
IABCN Ambassador Club Member, ICON Clinical Research, has extensive experience in glucose clamping at our clinical research unit. Click HERE to learn more.